Universal Scientific Industrial (Shanghai) (601231) Q4 2025 earnings summary

Executive summary

• Revenue for 2025 was RMB 59.20 billion, down 2.46% year-over-year, mainly due to declines in communication and automotive electronics, partially offset by growth in consumer and medical electronics.

• Net profit attributable to shareholders rose 12.16% year-over-year to RMB 1.85 billion, driven by improved operating profit and cost controls.

• Gross margin remained stable at 9.49%, while operating profit margin increased to 3.56% due to cost control and asset disposal gains.

• The company continued to expand overseas production capacity and invest in innovative businesses, especially in AI, cloud, and optical communications.

Financial highlights

• Operating revenue: RMB 59.20 billion (–2.46% YoY); net profit: RMB 1.85 billion (+12.16% YoY).

• Operating profit: RMB 2.11 billion (+12.39% YoY); total profit: RMB 2.14 billion (+15.41% YoY).

• Basic EPS: RMB 0.85 (+11.84% YoY); weighted average ROE: 9.98%.

• Net cash flow from operating activities: RMB 2.40 billion (–42.90% YoY).

• Dividend proposal: RMB 4.30 per 10 shares.

Outlook and guidance

• The company expects continued growth in AI, cloud, and optical communications, with further investment in Southeast Asia and digital transformation.

• Plans to maintain market share in SiP modules, expand miniaturization technology, and accelerate new product R&D.

• Focus on supply chain resilience, smart manufacturing, and sustainable development.